Explore evidence

4.4 %Sacubitril–valsartan was prescribed to 25 women (4.4%) and 101 men (6.8%) in the HFrEF subgroup.

TunisieHFrEFHAL · Unilimdocument of 95 observations

50 %Approximately 50% of individuals with diabetes in Tunisia are still undiagnosed.

Tunisiediabète (non précisé)HAL · Unilimdocument of 9 observations

60.7 %In the HFrEF subgroup, mineralocorticoid receptor antagonists (MRA) were prescribed to 342 women (60.7%) and 910 men (61.6%).

TunisieHFrEFHAL · Unilimdocument of 95 observations

60 %La prévalence de l'anticorps anti-HCV est de 60,0 % chez les patients atteints de carcinome hépatocellulaire en Tunisie et au Maroc (étude menée entre 2002 et 2005).

Tunisiecarcinome hépatocellulaire · hépatite Cobserved 2002 à 2005HAL · Unilimdocument of 199 observations

27.4 %Atrial fibrillation prevalence was significantly higher in women (27.4%) than in men (11.8%) in the Tunisian cohort of the MEA-WCVD registry.

Tunisieatrial fibrillationHAL · Unilimdocument of 95 observations

6.8 %Sacubitril–valsartan was prescribed to 101 men (6.8%) and 25 women (4.4%) in the HFrEF subgroup.

TunisieHFrEFHAL · Unilimdocument of 95 observations

5 casesThe incidence of imported malaria cases in Tunisia showed a gradually increasing trend from 5 cases in 2008 to 56 cases in 2022.

Tunisiepaludismeobserved 2008HAL · Unilimdocument of 123 observations

17.9 %La prévalence de l'antigène HBsAg est de 17,9 % chez les patients atteints de carcinome hépatocellulaire en Tunisie et au Maroc (étude menée entre 2002 et 2005).

Tunisiecarcinome hépatocellulaire · hépatite Bobserved 2002 à 2005HAL · Unilimdocument of 199 observations

3,400,000 deaths_per_yearDiabetes causes more than 3.4 million deaths per year globally.

Tunisiediabète (non précisé)HAL · Unilimdocument of 9 observations